Intervacc AB (publ) (STO:IVACC)
Sweden · Delayed Price · Currency is SEK 0.7655
-0.0065 (-0.84%)
Nov 2, 2026, 5:19 PM CET
Intervacc AB Market Cap
Intervacc AB has a market cap or net worth of 260.89 million as of November 2, 2026. It is the 34,645th most valuable company in the world and the 474th biggest in Sweden. Its market cap has decreased by 24.36% in one year.
Market Cap
260.89M
Enterprise Value
134.12M
Revenue
18.11M
Global Rank
Country Rank
#474 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since April 7, 2017, Intervacc AB's market cap has increased from 85.80M to 260.89M, an increase of 204.09%. That is a compound annual growth rate of 12.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 260.89M | -17.15% |
| Dec 30, 2025 | 314.91M | 255.38% |
| Dec 30, 2024 | 88.61M | -81.52% |
| Dec 29, 2023 | 479.41M | -63.48% |
| Dec 30, 2022 | 1.31B | -50.81% |
| Dec 30, 2021 | 2.67B | 0.76% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 7, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cantargia AB | 451.68M |
| Isofol Medical AB | 383.95M |
| Sprint Bioscience AB | 379.86M |
| Corline Biomedical AB | 371.09M |
| BioInvent International AB | 357.32M |
| Mendus AB | 352.63M |
| IRLAB Therapeutics AB | 310.81M |
| Xbrane Biopharma AB | 291.57M |